Quality by design (QbD) in the formulation and optimization of liquid crystalline nanoparticles (LCNPs): A risk based industrial approach
The intersection of lipid-based nanoparticles and lyotropic liquid crystals has provided a novel type of nanocarrier system known as ‘lipid-based lyotropic liquid crystals’ or ‘liquid crystalline nanoparticles’ (LCNPs). The unique advantages and immense popularity of LCNPs can be exploited in a bett...
Main Authors: | Tejashree Waghule, Neha Dabholkar, Srividya Gorantla, Vamshi Krishna Rapalli, Ranendra Narayan Saha, Gautam Singhvi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332221007228 |
Similar Items
-
QbD not QED
by: Shireesh Apte
Published: (2011-09-01) -
An Integrated Downstream Process Development Strategy along QbD Principles
by: Andrea Meitz, et al.
Published: (2014-10-01) -
QbD approach to HPLC method development and validation of ceftriaxone sodium
by: Krunal Y. Patel, et al.
Published: (2021-07-01) -
An Updated Risk Assessment as Part of the QbD-Based Liposome Design and Development
by: Zsófia Németh, et al.
Published: (2021-07-01) -
Fluidised bed granulation of two APIs: QbD approach and development of a NIR in-line monitoring method
by: Alexandru Gavan, et al.
Published: (2020-07-01)